BC
WST icon

Bartlett & Co’s West Pharmaceutical WST Stock Holding History

Bartlett & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$2K – 1184
2022
Q3 		$2K Sell
7
-9
-56% -$2.74K ﹤0.01% 1071
2022
Q2 		$5K Buy
+16
New +$5.21K ﹤0.01% 1026
2015
Q1 		– Sell
-169
Closed -$9K – 795
2014
Q4 		$9K Buy
+169
New +$8.45K ﹤0.01% 628

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bartlett & Co's WST Position: Q4 2022 in Review

Bartlett & Co sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 7 shares — an estimated $2K sold.

Bartlett & Co first reported a position in WST in Q4 2014 and held it in 3 quarters. The position peaked at $9K in Q4 2014. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Bartlett & Co reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Bartlett & Co sold 7 West Pharmaceutical shares in Q4 2022, an estimated $2K.
  • Bartlett & Co first reported a position in West Pharmaceutical in Q4 2014 and held it in 3 quarters.
  • Bartlett & Co's West Pharmaceutical position peaked at $9K in Q4 2014.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Bartlett & Co's 13F filing for Q4 2022, filed 4 Jan 2023.